第一选择
依氟鸟氨酸
:
儿童和成人:200mg/kg,静脉注射,每 12 小时一次,连续治疗 7 天
和
硝呋莫司
:
儿童和成人:5mg/kg,口服,每 8 小时一次,连续治疗 10 天
第二选择
依氟鸟氨酸
:
<12 岁的儿童:咨询专科医生以指导剂量;>12 岁的儿童和成人:100 mg/kg,静脉输注,每 6 小时一次,持续 14 天
第三选择
美拉胂醇
:
儿童和成人:2.2mg/kg,静脉注射,每日一次,连续治疗 10 天
更多
美拉胂醇
WHO 推荐采用此剂量方案;[2] World Health Organization. Control and surveillance of human African trypanosomiasis. Technical Report Series 984. Geneva, Switzerland: WHO; 2013.Full text CDC 推荐采用时间更长且剂量更复杂的治疗方案。[140] Centers for Disease Control and Prevention. Parasites - African trypanosomiasis (also known as sleeping sickness): resources for health professionals. August 2016 [internet publication].Full text
治疗期间禁止饮酒。
和
泼尼松龙
:
儿童和成人:1mg/kg,口服,每日一次
可以将静脉输注依氟鸟氨酸用作一线治疗药物,单药治疗或联合硝呋莫司使用皆可。[2]World Health Organization. Control and surveillance of human African trypanosomiasis. Technical Report Series 984. Geneva, Switzerland: WHO; 2013.http://apps.who.int/iris/bitstream/10665/95732/1/9789241209847_eng.pdf?ua=1[140]Centers for Disease Control and Prevention. Parasites - African trypanosomiasis (also known as sleeping sickness): resources for health professionals. August 2016 [internet publication].https://www.cdc.gov/parasites/sleepingsickness/health_professionals/index.html
依氟鸟氨酸作为单药治疗时需要以静脉输注方式连续治疗 14 天。[124]Priotto G, Pinoges L, Fursa IB, et al. Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. BMJ. 2008 Mar 29;336(7646):705-8.http://www.bmj.com/content/336/7646/705.fullhttp://www.ncbi.nlm.nih.gov/pubmed/18321960?tool=bestpractice.com[142]Balasegaram M, Harris S, Checchi F, et al. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull World Health Organ. 2006 Oct;84(10):783-91.http://www.ncbi.nlm.nih.gov/pubmed/17128358?tool=bestpractice.com[143]Chappuis F. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go. Clin Infect Dis. 2007 Dec 1;45(11):1443-5.http://www.ncbi.nlm.nih.gov/pubmed/17990226?tool=bestpractice.com[144]Balasegaram M, Young H, Chappuis F, et al. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Medecins Sans Frontieres programmes. Trans R Soc Trop Med Hyg. 2009 Mar;103(3):280-90.http://www.ncbi.nlm.nih.gov/pubmed/18947846?tool=bestpractice.com[145]Lutje V, Seixas J, Kennedy A. Chemotherapy for second-stage human African trypanosomiasis. Cochrane Database Syst Rev. 2013 Jun 28;(6):CD006201.http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006201.pub3/fullhttp://www.ncbi.nlm.nih.gov/pubmed/23807762?tool=bestpractice.com[146]Priotto G, Kasparian S, Mutombo W, et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet. 2009 Jul 4;374(9683):56-64.http://www.ncbi.nlm.nih.gov/pubmed/19559476?tool=bestpractice.com 依氟鸟氨酸联合使用硝呋莫司治疗已被用于临床实践,以减少依氟鸟氨酸单药治疗的持续时间和负荷,延缓耐药性的出现。[145]Lutje V, Seixas J, Kennedy A. Chemotherapy for second-stage human African trypanosomiasis. Cochrane Database Syst Rev. 2013 Jun 28;(6):CD006201.http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006201.pub3/fullhttp://www.ncbi.nlm.nih.gov/pubmed/23807762?tool=bestpractice.com[146]Priotto G, Kasparian S, Mutombo W, et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet. 2009 Jul 4;374(9683):56-64.http://www.ncbi.nlm.nih.gov/pubmed/19559476?tool=bestpractice.com[148]Alirol E, Schrumpf D, Amici Heradi J, et al. Nifurtimox-eflornithine combination therapy for second-stage Gambiense human African trypanosomiasis: Médecins sans Frontières experience in the Democratic Republic of the Congo. Clin Infect Dis. 2013 Jan;56(2):195-203.https://academic.oup.com/cid/article/56/2/195/318180/Nifurtimox-Eflornithine-Combination-Therapy-forhttp://www.ncbi.nlm.nih.gov/pubmed/23074318?tool=bestpractice.com 在无法获得硝呋莫司的地区,可以给予依氟鸟氨酸单药治疗。
可以将美拉胂醇与泼尼松龙联合用于(以预防美拉胂醇相关性脑病)疾病复发的患者。[2]World Health Organization. Control and surveillance of human African trypanosomiasis. Technical Report Series 984. Geneva, Switzerland: WHO; 2013.http://apps.who.int/iris/bitstream/10665/95732/1/9789241209847_eng.pdf?ua=1[142]Balasegaram M, Harris S, Checchi F, et al. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull World Health Organ. 2006 Oct;84(10):783-91.http://www.ncbi.nlm.nih.gov/pubmed/17128358?tool=bestpractice.com[149]Schmid C, Richer M, Bilenge CM, et al. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (Impamel II). J Infect Dis. 2005 Jun 1;191(11):1922-31.https://academic.oup.com/jid/article/191/11/1922/2191985/Effectiveness-of-a-10-Day-Melarsoprol-Schedule-forhttp://www.ncbi.nlm.nih.gov/pubmed/15871127?tool=bestpractice.com 推荐在使用过程中密切监测血液参数、肾功能和肝功能。治疗期间禁止饮酒。
目前针对人类非洲锥虫病(HAT)感染儿童患者的治疗数据有限,但是一般来说,对 儿童的治疗通常遵循与成人相同的治疗方案。[151]Eperon G, Schmid C, Loutan L, et al. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta Trop. 2007 Jan;101(1):31-9.http://www.ncbi.nlm.nih.gov/pubmed/17207760?tool=bestpractice.com 曾有报告称对未满 12 岁儿童采用依氟鸟氨酸治疗,其生物利用度较低。 因此,给予儿童患者依氟鸟氨酸单药治疗时,须增加给药剂量。[152]Milord F, Pepin J, Loko L, et al. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet. 1992 Sep 12;340(8820):652-5.http://www.ncbi.nlm.nih.gov/pubmed/1355219?tool=bestpractice.com
可以从世界卫生组织的疾病创新和强化管理 (WHO's Innovative and Intensified Disease Management, IDM) 项目免费获取所有推荐药物。[139]Simarro PP, Franco J, Diarra A, et al. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology. 2012 Jun;139(7):842-6.http://www.ncbi.nlm.nih.gov/pubmed/22309684?tool=bestpractice.com